CDC42BPA inhibition for high-grade serous ovarian carcinoma

By Claire Quang | Apr 2, 2020 | 7:25 PM GMT

DISEASE CATEGORY: Cancer

INDICATION: Ovarian cancer

Inhibition of CDC42BPA alone or in combination with carboplatin and PAK1 inhibition could

Read the full 179 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE